Similarly, a mouse model of the human HIF-2α gain-of-function mutation recapitulated the phenotype of excessive erythrocytosis and pulmonary hypertension in a dose-dependent manner (86). This evidence concerns the gene EPAS1 and pulmonary hypertension.